rs121918115
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PM5PP3_Strong
The NM_004320.6(ATP2A1):c.2366C>G(p.Pro789Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000658 in 152,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P789L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_004320.6 missense
Scores
Clinical Significance
Conservation
Publications
- Brody myopathyInheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004320.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP2A1 | NM_004320.6 | MANE Select | c.2366C>G | p.Pro789Arg | missense | Exon 17 of 23 | NP_004311.1 | ||
| ATP2A1 | NM_173201.5 | c.2366C>G | p.Pro789Arg | missense | Exon 17 of 22 | NP_775293.1 | |||
| ATP2A1 | NM_001286075.2 | c.1991C>G | p.Pro664Arg | missense | Exon 15 of 21 | NP_001273004.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP2A1 | ENST00000395503.9 | TSL:1 MANE Select | c.2366C>G | p.Pro789Arg | missense | Exon 17 of 23 | ENSP00000378879.5 | ||
| ATP2A1 | ENST00000357084.7 | TSL:2 | c.2366C>G | p.Pro789Arg | missense | Exon 17 of 22 | ENSP00000349595.3 | ||
| ATP2A1 | ENST00000536376.5 | TSL:2 | c.1991C>G | p.Pro664Arg | missense | Exon 15 of 21 | ENSP00000443101.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152086Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251412 AF XY: 0.00 show subpopulations
GnomAD4 exome Cov.: 32
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152086Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74286 show subpopulations
ClinVar
Submissions by phenotype
Brody myopathy Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 789 of the ATP2A1 protein (p.Pro789Arg). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ATP2A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 647518). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at